UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 28, 2014

 

 

BioMed Realty Trust, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   1-32261   20-1142292

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File No.)

 

(I.R.S. Employer

Identification No.)

17190 Bernardo Center Drive

San Diego, California 92128

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (858) 485-9840

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 28, 2014, BioMed Realty Trust, Inc. (the “Company”) held its Annual Meeting of Stockholders, at which the stockholders voted on proposals as follows:

Proposal 1: Election of seven directors to serve until the 2015 Annual Meeting of Stockholders and until their successors are duly elected and qualify.

 

     Votes For      Votes
Against
     Abstentions      Broker
Non-Votes
 

Alan D. Gold

     158,139,062         2,212,532         3,779,189         8,372,493   

Daniel M. Bradbury

     139,892,844         3,293,783         20,944,156         8,372,493   

William R. Brody

     162,382,697         47,390         1,700,696         8,372,493   

Gary A. Kreitzer

     163,823,751         45,248         261,784         8,372,493   

Theodore D. Roth

     159,130,838         3,325,310         1,674,635         8,372,493   

Janice L. Sears

     163,806,940         63,677         260,166         8,372,493   

M. Faye Wilson

     161,682,231         704,332         1,744,220         8,372,493   

Proposal 2: Ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2014.

 

Votes For

   Votes Against    Abstentions    Broker Non-Votes
170,611,751    1,716,045    175,480    N/A
Proposal 3: Resolution to approve, on an advisory basis, the compensation of the Company’s named executive officers.

Votes For

   Votes Against    Abstentions    Broker Non-Votes
100,796,348    63,083,489    250,946    8,372,493


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 30, 2014

    BIOMED REALTY TRUST, INC.
    By:  

/s/ GREG N. LUBUSHKIN

    Name:   Greg N. Lubushkin
    Title:   Chief Financial Officer